Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Narayana Hrudayalaya Ltd (NARY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,271.00 -4.50    -0.35%
06:00:02 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE410P01011 
S/N:  NH
  • Volume: 373,170
  • Bid/Ask: 1,266.00 / 1,271.50
  • Day's Range: 1,255.60 - 1,285.00
Narayana Hrudayalaya 1,271.00 -4.50 -0.35%

Narayana Hrudayalaya Ltd Company Profile

 
Get an in-depth profile of Narayana Hrudayalaya Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

11923

Equity Type

ORD

Narayana Hrudayalaya Limited provides medical and healthcare services in India and internationally. The company acquires, owns, and operates hospitals, clinics, health centers, and nursing homes. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Contact Information

Address 261/A, Bommasandra Industrial Area 2nd Floor
Anekal Taluk Bengaluru, 560099
India
Phone 91 80 7122 2636
Fax 91 80 2783 2648

Top Executives

Name Age Since Title
Devi Prasad Shetty 69 2000 Founder & Executive Chairman
Emmanuel Rupert 55 2018 MD, Group CEO & Director
Viren Prasad Shetty 39 2008 Executive Vice-Chairman and Senior VP of Strategy & Planning
Kiran Mazumdar Shaw 70 2008 Non-Executive Director
Nachiket Madhusudan Mor 59 2023 Independent Director
Terri Smith Bresenham 63 2021 Independent Director
Naveen Tewari - 2023 Independent Director
Shankar Arunachalam - 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NARY Comments

Write your thoughts about Narayana Hrudayalaya Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Umesh Goswami
Umesh Goswami Aug 06, 2021 2:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy JAYSREETEA at 122-125 Short term target 140 to 150 long term target 180 to 400++ ( Huge demand of tea )
Rex Eapen
Rex Eapen Mar 13, 2020 5:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when do you think I should enter this stock?
kaushal Joshi
kaushal Joshi Mar 13, 2020 5:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
kaushal Joshi
kaushal Joshi Mar 13, 2020 5:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
Nitish Gupta
Nitish Gupta Jan 16, 2020 6:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mark my words this stock will be a gem in future. Clean promoters and solid business model. Margin expansion will take some time. As soon as that happens and occupany level increases in north india hospitals this would not be available even at 450.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email